Monographie - Octreotide acetate

viimane versioon :
19/11/2024

Octreotide acetate

keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Akroken	Mehhiko
Badastin	Ecuador
Bendatreotid	Egiptus
Cryostatin	Mehhiko
Gasterina	Argentiina, Tšiili
Jintrotide	Maroko
Longastatina	Itaalia
Nomactril	Mehhiko
Ocphyl	Kanada
Octate	India
Octide	India
Octotide	Ecuador
Octreotid	Saksamaa
Octreotida	Hispaania
Octreotide	Ameerika ühendriigid, Kanada, Suurbritannia
Octride	Ecuador, Kolumbia
Samilstin	Itaalia
Sandostatin	Ameerika ühendriigid, Araabia Ühendemiraadid, Argentiina, Austraalia, Austria, Brasiilia, Ecuador, Hispaania, Iirimaa, Island, Kanada, Kreeka, Luksemburg, Malaisia, Norra, Poola, Rootsi, Rumeenia, Saksamaa, Sloveenia, Soome, Suurbritannia, Sveits, Taani, Tšiili, Türgi, Ungari, uus-Meremaa
Sandostatina	Itaalia, Portugal
Sandostatine	Belgia, Holland, Maroko, Portugal, Prantsusmaa
Secrestat	Kolumbia
Siroctid	Belgia

Viited : Octreotide acetate

	tüüp	avaldamine
127	ajaleht	Ripley RG, Ritchie DJ, Holstad SG. Stability of octreotide acetate in polypropylene syringes at 5 and -20°C. Am J Health-Syst Pharm 1995 ; 52: 1910-1911.
294	ajaleht	Stiles ML, Allen LV, Resztak KE, Prince SJ. Stability of octreotide acetate in polypropylene syringes. Am J Hosp Pharm 1993 ; 50: 2356-2358.
301	ajaleht	Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
466	ajaleht	Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM. Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm 1991 ; 48: 2172-2175.
1415	ajaleht	Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN 1999 ; 23: 67-74.
1508	ajaleht	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1902	ajaleht	Walker SE, Wyllie A, Law S. Physical compatibility of pantoprazole with selected medications during simulated Y-site administration. Can J Hosp Pharm 2004 ; 57, 2: 90-96.
2087	ajaleht	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	ajaleht	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2108	ajaleht	Trusley C, Kupiec TC, Trissel LA. Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Int J Pharm Compound 2006 ; 10: 230-232.
2404	ajaleht	Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med 2000 ; 14: 205-208.
3216	ajaleht	Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel 2011 ; 44, 1 : 14-18
3408	ajaleht	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3767	ajaleht	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3824	ajaleht	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3828	plakat	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakat	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3948	ajaleht	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4055	ajaleht	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4086	Labor	Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit Novartis Pharma 2017
4145	ajaleht	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434	ajaleht	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4528	ajaleht	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4603	ajaleht	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4742	ajaleht	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.
4768	ajaleht	Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H. Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school 2023
4801	ajaleht	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales